Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Three more years for Ethicon/Neoprobe distribution pact:

This article was originally published in Clinica

Executive Summary

Ethicon Endo-Surgery is to distribute Dublin, Ohio-based Neoprobe's neo2000 gamma detection system through to December 2008, following a renewal of the companies' existing contract. The Johnson & Johnson subsidiary has been worldwide distributor (except in Japan) of the system since 1999. The neo2000 is used for performing a sentinel lymph node biopsy (SLNB), which traces the lymphatic patterns in a cancer patient to assess potential tumour drainage and cancer spread in lymphatic tissue. The technique does not detect cancer but helps surgeons to identify the lymph nodes to which a tumour is likely to drain and spread.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT051135

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel